The information highlighted (if any) are the most recent updates for this brand.
There is limited clinical trial experience regarding human overdosage with REXULTI. ECG monitoring is recommended in the event of overdose. Otherwise, management of overdose should concentrate on supportive therapy, maintaining an adequate airway, oxygenation and ventilation, and management of symptoms. Close medical supervision and monitoring should continue until the patient recovers.